Option Chain

Glaukos Corp

GKOSNYSE · USD

224.41USD+4.43 (+2.02%)

5710

Glaukos Corp (GKOS) Option Chain

Glaukos Corp trades at $224.41, up 2.02%, with an IV Rank of 63.10%. This is average versus the past year, and the company carries a market cap of $13,022M in the Medical Devices industry. On the Nov 20, 2026 chain, the at the money $220.00 strike shows calls at $9.80 / $12.90 and puts at $10.50 / $13.20, both carrying about $9.40 of extrinsic value and a roughly 50% probability of expiring out of the money. Volume is heaviest on the $200.00 calls, at 160 contracts, and the $230.00 puts, at 2,013, as of Nov 5, 2026.

Tracking the GKOS option chain helps you see every strike and expiry on Glaukos Corp in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of GKOS options activity at a glance. Use our scanner to monitor the GKOS option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For GKOS stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where GKOS options are being actively traded, and where they are not.

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication.

CALLs									PUTs
Prob. OTM %	Open Interest	Volume	Extrinsic Value	Intrinsic Value	Bid	Ask	Strike	Moneyness %	Bid	Ask	Intrinsic Value	Extrinsic Value	Volume	Open Interest	Prob. OTM %
22.63	388	160	-0.26	24.41	22.80	25.50	200.00	-9.08	2.30	6.00	0.00	4.15	101	136	77.37
36.59	25	0	2.64	14.41	15.60	18.50	210.00	-4.54	6.20	9.00	0.00	7.60	83	10	63.41
51.87	37	0	6.94	4.41	9.80	12.90	220.00	+0.01	10.50	13.20	0.00	11.85	315	55	48.13
66.24	20	2	7.15	0.00	5.80	8.50	230.00	+4.55	15.70	18.50	5.59	11.51	2,013	41	33.76
78.10	19	1	4.38	0.00	2.75	6.00	240.00	+9.10	23.20	26.00	15.59	9.01	28	49	21.90

As of Nov 5, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →

Stock Statistics

IndustryMedical Devices
SectorHealthcare
IV Rank63.10% Moderate
Market cap (M$)13,022
52 weeks high-13.79%
52 weeks low171.92%
Analyst recommendationStrong Buy
1.27
Target price$242.46
4.92% above the current stock price
Dividend—
Payout ratio—
Earnings date2026-10-28
P/E—
Future P/E157.09
EPS (ttm)-2.94
EPS growth next 5 years—

As of Nov 5, 2026

Browse all Option Chain tickers